RAC 0.97% $1.54 race oncology ltd

Pillar 1 - FTO (new thread), page-1475

  1. 8,428 Posts.
    lightbulb Created with Sketch. 1386
    Mason I agree with 99% of what you say.

    But 18097 specificity looks good:

    "IC50 value of 18097, the most potent FTO inhibitor, was 179 μmol/L for ALKBH5 (Fig. S2G), which is about280-fold greater than that to FTO."

    I can't find the corresponding number for bisantrene and ALKBH5 in Su et al.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.